Cargando…
Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma
Osteosarcoma (OS) is the most common primary bone tumor in children and young people. Traditional surgical excision combined with chemotherapy presents many limitations, such as resistance and systemic side effects of chemotherapy drugs, postoperative recurrence, and bone defects. Given these limita...
Autores principales: | Wu, Kunzhe, Yu, Beibei, Li, Di, Tian, Yangyang, Liu, Yan, Jiang, Jinlan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885548/ https://www.ncbi.nlm.nih.gov/pubmed/35242707 http://dx.doi.org/10.3389/fonc.2022.805978 |
Ejemplares similares
-
Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA
por: Zhao, Jingtong, et al.
Publicado: (2023) -
Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy
por: Ma, Yifan, et al.
Publicado: (2021) -
Bioinspired Membrane-Coated Nanoplatform for Targeted Tumor Immunotherapy
por: Mu, Dan, et al.
Publicado: (2022) -
Exosomes as Smart Nanoplatforms for Diagnosis and Therapy of Cancer
por: Zhao, Yuying, et al.
Publicado: (2021) -
Recent advances of CREKA peptide-based nanoplatforms in biomedical applications
por: Zhang, Nannan, et al.
Publicado: (2023)